Sign inJoin waitlistJoin the waitlist

ZE

Zeynep Eroglu

Physician · H. Lee Moffitt Cancer Center and Research Institute

Credentials: · · · ·

History

H. Lee Moffitt Cancer Center and Research Institute
Present

Hematology and Medical Oncology
University of Southern California/Los Angeles General Medical Center
2012–2015
University of California
2008–2011
David Geffen Sch of Med at UCLA
2004–2008

Research

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
Systematic review or meta-analysis · JAMA Oncology · 2018 · 2,273 citations
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
Annals of Oncology · 2017 · 644 citations
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma
Annals of Oncology · 2018 · 336 citations

NK
Nikhil Khushalani
40 papers
Vernon Sondak
33 papers
Douglas Johnson
31 papers
JM
Joseph Markowitz
27 papers
AB
Andrew Brohl
25 papers
AT
Ahmad Tarhini
20 papers
Jeffrey Sosman
20 papers
Jonathan Zager
17 papers
Antoni Ribas
16 papers
Jane Messina
15 papers
AS
Amod Sarnaik
13 papers
Kenneth Tsai
11 papers

Clinical trials

Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
Principal investigator · Recruiting · Early phase 1
H. Lee Moffitt Cancer Center and Research Institute
2023–2029
Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
Principal investigator · Active not recruiting · Phase 2
H. Lee Moffitt Cancer Center and Research Institute
2021–2028
Axitinib + Ipilimumab in Advanced Melanoma
Principal investigator · Active not recruiting · Phase 2
H. Lee Moffitt Cancer Center and Research Institute
2021–2027
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
Principal investigator · Recruiting · Early phase 1
H. Lee Moffitt Cancer Center and Research Institute
2021–2027